Johnson & Johnson to buy Momenta for about $6.5 billion
J&J will pay $52.50 for each Momenta share, a 70.4 percent premium to Tuesday’s closing price
FILE PHOTO: The company logo for Johnson & Johnson is displayed on a screen to celebrate the 75th anniversary of the company's listing at the New York Stock Exchange (NYSE) in New York, US, September 17, 2019. REUTERS/Brendan McDermid/File Photo
Johnson & Johnson said on Wednesday it would buy Momenta Pharmaceuticals Inc for about $6.5 billion in cash to expand into the area of autoimmune disease treatments.
J&J will pay $52.50 for each Momenta share, a 70.4 percent premium to Tuesday's closing price.
Keep updated, follow The Business Standard's Google news channel
